Substitute House Bill 290 Summary

• Permits patients with terminal conditions to access investigational drugs, products, or devices not yet approved by the FDA, provided they meet specific eligibility requirements and obtain informed consent.

• Establishes that manufacturers and healthcare providers providing investigational treatments are not liable for civil, criminal, or professional disciplinary action unless willful or wanton misconduct occurs.

• Allows health care professionals to earn continuing education credits by providing volunteer health care services to indigent and uninsured persons, up to one-third of their continuing education requirements.

• Modifies laws governing county home superintendent or administrator appointments, allowing boards of county commissioners to contract with public or private entities to select these positions.

• Makes conforming changes to pharmacy and medical board regulations to accommodate the new right-to-try provisions for terminally ill patients.